Insmed Inc. buy Barclays PLC
Start price
29.05.24
/
50%
€43.00
Target price
29.05.25
€58.07
Performance (%)
43.02%
End price
30.05.25
€61.50
Summary
This prediction ended on 30.05.25 with a price of €61.50. The BUY prediction by Barclays_PLC for Insmed Inc. saw massive gains of 43.02%. Barclays_PLC has a follow-up prediction for Insmed Inc. where he still thinks Insmed Inc. is a Buy. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Insmed Inc. | -3.410% | -3.410% | 1.358% |
| iShares Core DAX® | -0,87 % | 5,32 % | 6,86 % |
| iShares Nasdaq 100 | -0,38 % | 1,98 % | 25,70 % |
| iShares Nikkei 225® | -1,68 % | 1,95 % | 41,44 % |
| iShares S&P 500 | -0,65 % | 2,07 % | 21,40 % |
Comments by Barclays_PLC for this prediction
In the thread Insmed Inc. diskutieren
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at Barclays PLC from $40.00 to $63.00. They now have an "overweight" rating on the stock.
Ratings data for INSM provided by MarketBeat
In the thread Trading Insmed Inc.
Die von Barclays_PLC gewählte maximale Laufzeit wurde überschritten